ctrl K

Immunocore (IMCR)

NASDAQ: IMCR · Real-Time Price · USD

30.15

0.05 (0.17%)

At close: May 01, 2025, 3:59 PM

30.15

0.00%

After-hours: May 01, 2025, 04:42 PM EDT

Immunocore Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	310.2M	249.43M	143.74M	26.52M	30.11M	25.67M	23.65M
Cost of Revenue	2.73M	1.04M	454K	73.23M	74.81M	99.99M	n/a
Gross Profit	307.47M	248.39M	143.28M	-46.71M	-44.7M	-74.32M	23.65M
Operating Income	-70.46M	-59.65M	-39.61M	-135.16M	-86.19M	-118.32M	-93.45M
Interest Income	25.62M	17.99M	3.15M	47K	706K	1.4M	822K
Pretax Income	-52.94M	-60.89M	-44.15M	-140.93M	-87.36M	-126.19M	-88.18M
Net Income	-51.09M	-55.29M	-41.22M	-131.52M	-74.09M	-103.93M	-71.63M
Selling & General & Admin	155.78M	144.5M	93.72M	88.4M	45.74M	44.18M	34.16M
Research & Development	222.15M	163.54M	89.17M	73.23M	74.81M	99.99M	83.58M
Other Expenses	n/a	n/a	-3K	57K	-1.15M	185K	5.6M
Operating Expenses	377.93M	308.04M	182.89M	161.68M	119.4M	144.17M	117.73M
Interest Expense	18.84M	5.15M	7.69M	5.81M	3.11M	3.8M	842K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	99.99M	83.58M
Cost & Expenses	380.66M	309.08M	183.34M	161.68M	119.4M	144.17M	117.73M
Income Tax Expense	-1.85M	-5.6M	-2.92M	-9.4M	-13.27M	-22.26M	-16.55M
Shares Outstanding (Basic)	49.99M	48.89M	45.71M	42.49M	31.78M	27.31M	27.31M
Shares Outstanding (Diluted)	49.99M	48.89M	45.71M	43.86M	31.78M	27.31M	27.31M
EPS (Basic)	-1.02	-1.13	-0.9	-3.1	-2.33	-3.81	-2.62
EPS (Diluted)	-1.02	-1.13	-0.9	-3	-2.33	-3.81	-2.62
EBITDA	-70.46M	-51.65M	-38.35M	-166.72M	-102.59M	-113.18M	-86.75M
EBIT	-71.78M	-55.74M	-35.47M	-174.31M	-114.82M	-122.39M	-87.34M
Depreciation & Amortization	1.32M	4.09M	5.33M	7.59M	8.98M	9.21M	6.71M